                         SEQUENCE LISTING

<110>  BIOPHARMA TRANSLATIONSINSTITUT DESSAU FORSCHUNGS GMBH
 
<120>  Trypsin mutant for C- and N-terminal modification of polypeptides

<130>  P39457-WO

<150>  EP 18205212.6
<151>  2018-11-08

<160>  60    

<170>  PatentIn version 3.5

<210>  1
<211>  223
<212>  PRT
<213>  Rattus norvegicus

<220>
<223>  mature anionic rat trypsin II 

<400>  1

Ile Val Gly Gly Tyr Thr Cys Gln Glu Asn Ser Val Pro Tyr Gln Val 
1               5                   10                  15      


Ser Leu Asn Ser Gly Tyr His Phe Cys Gly Gly Ser Leu Ile Asn Asp 
            20                  25                  30          


Gln Trp Val Val Ser Ala Ala His Cys Tyr Lys Ser Arg Ile Gln Val 
        35                  40                  45              


Arg Leu Gly Glu His Asn Ile Asn Val Leu Glu Gly Asn Glu Gln Phe 
    50                  55                  60                  


Val Asn Ala Ala Lys Ile Ile Lys His Pro Asn Phe Asp Arg Lys Thr 
65                  70                  75                  80  


Leu Asn Asn Asp Ile Met Leu Ile Lys Leu Ser Ser Pro Val Lys Leu 
                85                  90                  95      


Asn Ala Arg Val Ala Thr Val Ala Leu Pro Ser Ser Cys Ala Pro Ala 
            100                 105                 110         


Gly Thr Gln Cys Leu Ile Ser Gly Trp Gly Asn Thr Leu Ser Ser Gly 
        115                 120                 125             


Val Asn Glu Pro Asp Leu Leu Gln Cys Leu Asp Ala Pro Leu Leu Pro 
    130                 135                 140                 


Gln Ala Asp Cys Glu Ala Ser Tyr Pro Gly Lys Ile Thr Asp Asn Met 
145                 150                 155                 160 


Val Cys Val Gly Phe Leu Glu Gly Gly Lys Asp Ser Cys Gln Gly Asp 
                165                 170                 175     


Ser Gly Gly Pro Val Val Cys Asn Gly Glu Leu Gln Gly Ile Val Ser 
            180                 185                 190         


Trp Gly Tyr Gly Cys Ala Leu Pro Asp Asn Pro Gly Val Tyr Thr Lys 
        195                 200                 205             


Val Cys Asn Tyr Val Asp Trp Ile Gln Asp Thr Ile Ala Ala Asn 
    210                 215                 220             


<210>  2
<211>  245
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-Her2-Fab-YRAH heavy chain

<400>  2

Glu Val Lys Leu Gln Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn Ile Lys Asp Thr 
            20                  25                  30          


Tyr Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Arg Ile Tyr Pro Thr Asn Gly Tyr Thr Arg Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ser Arg Trp Gly Gly Asp Gly Phe Tyr Ala Met Asp Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val 
        115                 120                 125             


Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala 
    130                 135                 140                 


Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser 
145                 150                 155                 160 


Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val 
                165                 170                 175     


Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro 
            180                 185                 190         


Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys 
        195                 200                 205             


Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser Cys Ala 
    210                 215                 220                 


Asp Lys Pro Gly Gly Tyr Arg Ala His Ala Gly Glu Gln Lys Leu Ile 
225                 230                 235                 240 


Ser Glu Glu Asp Leu 
                245 


<210>  3
<211>  214
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-Her2-Fab-YRAH light chain

<400>  3

Asp Ile Glu Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Val Asn Thr Ala 
            20                  25                  30          


Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln His Tyr Thr Thr Pro Pro 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val Ala Ala 
            100                 105                 110         


Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly 
        115                 120                 125             


Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala 
    130                 135                 140                 


Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln 
145                 150                 155                 160 


Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser 
                165                 170                 175     


Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr 
            180                 185                 190         


Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser 
        195                 200                 205             


Phe Asn Arg Gly Glu Cys 
    210                 


<210>  4
<211>  184
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Strep-YRAH-cyclophilin18

<400>  4

Gly Trp Ser His Pro Gln Phe Glu Lys Tyr Arg Ala His Ala Val Asn 
1               5                   10                  15      


Pro Thr Val Phe Phe Asp Ile Ala Val Asp Gly Glu Pro Leu Gly Arg 
            20                  25                  30          


Val Ser Phe Glu Leu Phe Ala Asp Lys Val Pro Lys Thr Ala Glu Asn 
        35                  40                  45              


Phe Arg Ala Leu Ser Thr Gly Glu Lys Gly Phe Gly Tyr Lys Gly Ser 
    50                  55                  60                  


Cys Phe His Arg Ile Ile Pro Gly Phe Met Cys Gln Gly Gly Asp Phe 
65                  70                  75                  80  


Thr Arg His Asn Gly Thr Gly Gly Lys Ser Ile Tyr Gly Glu Lys Phe 
                85                  90                  95      


Glu Asp Glu Asn Phe Ile Leu Lys His Thr Gly Pro Gly Ile Leu Ser 
            100                 105                 110         


Met Ala Asn Ala Gly Pro Asn Thr Asn Gly Ser Gln Phe Phe Ile Cys 
        115                 120                 125             


Thr Ala Lys Thr Glu Trp Leu Asp Gly Lys His Val Val Phe Gly Lys 
    130                 135                 140                 


Val Lys Glu Gly Met Asn Ile Val Glu Ala Met Glu Arg Phe Gly Ser 
145                 150                 155                 160 


Arg Asn Gly Lys Thr Ser Lys Lys Ile Thr Ile Ala Asp Cys Gly Gln 
                165                 170                 175     


Leu Ala Tyr Arg His Ala Ala Gly 
            180                 


<210>  5
<211>  449
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-Her2-antibody RAH-Trastuzumab heavy chain

<400>  5

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn Ile Lys Asp Thr 
            20                  25                  30          


Tyr Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Arg Ile Tyr Pro Thr Asn Gly Tyr Thr Arg Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ser Arg Trp Gly Gly Asp Gly Phe Tyr Ala Met Asp Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val 
        115                 120                 125             


Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala 
    130                 135                 140                 


Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser 
145                 150                 155                 160 


Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val 
                165                 170                 175     


Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro 
            180                 185                 190         


Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys 
        195                 200                 205             


Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser Cys Asp 
    210                 215                 220                 


Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly 
225                 230                 235                 240 


Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile 
                245                 250                 255     


Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu 
            260                 265                 270         


Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His 
        275                 280                 285             


Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg 
    290                 295                 300                 


Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys 
305                 310                 315                 320 


Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu 
                325                 330                 335     


Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr 
            340                 345                 350         


Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu 
        355                 360                 365             


Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp 
    370                 375                 380                 


Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val 
385                 390                 395                 400 


Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp 
                405                 410                 415     


Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His 
            420                 425                 430         


Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro 
        435                 440                 445             


Gly 
    


<210>  6
<211>  218
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-Her2-antibody RAH-Trastuzumab light chain

<400>  6

Arg Ala His Ala Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser 
1               5                   10                  15      


Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp 
            20                  25                  30          


Val Asn Thr Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro 
        35                  40                  45              


Lys Leu Leu Ile Tyr Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Ser 
    50                  55                  60                  


Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
65                  70                  75                  80  


Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln His Tyr 
                85                  90                  95      


Thr Thr Pro Pro Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg 
            100                 105                 110         


Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln 
        115                 120                 125             


Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr 
    130                 135                 140                 


Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser 
145                 150                 155                 160 


Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr 
                165                 170                 175     


Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys 
            180                 185                 190         


His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro 
        195                 200                 205             


Val Thr Lys Ser Phe Asn Arg Gly Glu Cys 
    210                 215             


<210>  7
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  7

Tyr Arg Ala Ala Gly 
1               5   


<210>  8
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  8

Tyr Arg His Ala Ala Gly 
1               5       


<210>  9
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  9

Tyr Arg Ala His Ala Ala Gly 
1               5           


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  10

Ala Ala Tyr Arg Ala Ala His Ala Gly 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  11

Ala Ala Tyr Arg Ala His Ala Ala Gly 
1               5                   


<210>  12
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  12

Ala Ala Tyr Arg His Ala Ala Ala Gly 
1               5                   


<210>  13
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  13

Ala His Ala Gly 
1               


<210>  14
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  14

Ala Ala His Ala Gly 
1               5   


<210>  15
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  15

Arg Ala His Ala Lys 
1               5   


<210>  16
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  16

Arg Ala Ala His Lys 
1               5   


<210>  17
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  17

Arg His Ala Lys 
1               


<210>  18
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  18

Arg Ala His Ala Lys 
1               5   


<210>  19
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  19

Pro Gly Gly Tyr Arg Lys Asp Ala Gly 
1               5                   


<210>  20
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  20

Pro Gly Gly Tyr Arg Lys Lys Ala Gly 
1               5                   


<210>  21
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  21

Pro Gly Gly Tyr Arg Lys Asn Ala Gly 
1               5                   


<210>  22
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  22

Pro Gly Gly Tyr Arg Lys Ala Ala Gly 
1               5                   


<210>  23
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide

<400>  23

Pro Gly Gly Tyr Arg Arg His Ala Gly 
1               5                   


<210>  24
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence

<400>  24

Pro Gly Gly Tyr Asp Lys His Ala Gly 
1               5                   


<210>  25
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  25

Pro Gly Gly Tyr Ala Lys His Ala Gly 
1               5                   


<210>  26
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  26

Pro Gly Gly Ala Arg Lys His Ala Gly 
1               5                   


<210>  27
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  27

Pro Gly Gly Asp Arg Lys His Ala Gly 
1               5                   


<210>  28
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  28

Pro Gly Gly Arg Arg Lys His Ala Gly 
1               5                   


<210>  29
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  29

Pro Gly Gly Leu Arg Lys His Ala Gly 
1               5                   


<210>  30
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  30

Pro Gly Gly Trp Arg Lys His Ala Gly 
1               5                   


<210>  31
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  31

Pro Gly Gly Phe Arg Lys His Ala Gly 
1               5                   


<210>  32
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  32

Pro Gly Gly Tyr Arg Lys His Ala Gly 
1               5                   


<210>  33
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  33

Pro Gly Gly Tyr Arg Ala Asp Ala Gly 
1               5                   


<210>  34
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  34

Pro Gly Gly Tyr Arg Ala Lys Ala Gly 
1               5                   


<210>  35
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  35

Pro Gly Gly Tyr Arg Ala Asn Ala Gly 
1               5                   


<210>  36
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  36

Pro Gly Gly Tyr Arg Ala Ala Ala Gly 
1               5                   


<210>  37
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  37

Pro Gly Gly Tyr Lys Ala His Ala Gly 
1               5                   


<210>  38
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence

<400>  38

Pro Gly Gly Tyr Asp Ala His Ala Gly 
1               5                   


<210>  39
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  39

Pro Gly Gly Tyr Ala Ala His Ala Gly 
1               5                   


<210>  40
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  40

Pro Gly Gly Ala Arg Ala His Ala Gly 
1               5                   


<210>  41
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  41

Pro Gly Gly Asp Arg Ala His Ala Gly 
1               5                   


<210>  42
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  42

Pro Gly Gly Arg Arg Ala His Ala Gly 
1               5                   


<210>  43
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  43

Pro Gly Gly Trp Arg Ala His Ala Gly 
1               5                   


<210>  44
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  44

Pro Gly Gly Phe Arg Ala His Ala Gly 
1               5                   


<210>  45
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  45

Pro Gly Gly Tyr Arg Ala His Ala Gly 
1               5                   


<210>  46
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  46

Arg Lys Asp Ala Lys 
1               5   


<210>  47
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  47

Arg Lys Lys Ala Lys 
1               5   


<210>  48
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  48

Asx Arg Lys Asn Ala Lys 
1               5       


<210>  49
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  49

Arg Lys Ala Ala Lys 
1               5   


<210>  50
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  50

Arg Arg His Ala Lys 
1               5   


<210>  51
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  51

Asp Lys His Ala Lys 
1               5   


<210>  52
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  52

Ala Lys His Ala Lys 
1               5   


<210>  53
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  53

Arg Lys His Ala Lys 
1               5   


<210>  54
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  54

Arg Ala Asp Ala Lys 
1               5   


<210>  55
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  55

Arg Ala Lys Ala Lys 
1               5   


<210>  56
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  56

Arg Ala Asn Ala Lys 
1               5   


<210>  57
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  57

Arg Ala Ala Ala Lys 
1               5   


<210>  58
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  58

Lys Ala His Ala Lys 
1               5   


<210>  59
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  59

Asp Ala His Ala Lys 
1               5   


<210>  60
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223> polypeptide

<400>  60

Ala Ala His Ala Lys 
1               5   


